Core Biopsy Devices Market Growing at CAGR — 2026 Report

Core Biopsy Devices by Application (Hospital, Clinic, Others), by Types (Vacuum-assisted Biopsy Devices, Image-guided Single-cylinder Excision Alternatives), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $5200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $5200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Core Biopsy Devices Market Overview

Core biopsy devices are minimally invasive instruments that retrieve cylindrical tissue samples for histopathological analysis, enabling accurate diagnosis of oncological and non‑oncological lesions. The Core Biopsy Devices market size is projected to reach approximately $1.5 billion in 2025, with a market forecast indicating a CAGR of about 6 % from 2026 to 2033. This growth outlook is driven by rising cancer incidence, an aging global population, expanding outpatient diagnostic procedures, and continuous innovations such as vacuum‑assisted and imaging‑integrated systems. Key forces shaping the industry include rapid technology adoption (e.g., automated and vacuum‑assisted platforms), evolving regulatory pathways that streamline device approvals, and intensified competitive dynamics as major players expand their product portfolios. North America remains the largest market, while the Asia‑Pacific region is emerging as the fastest‑growing segment due to increasing healthcare expenditures and expanding screening programs.

Loading chart…

The stacked segment analysis underscores the accelerating adoption of vacuum‑assisted technology, which now accounts for over 70 % of total market revenue by 2033. Regulatory harmonization across major economies is fostering faster product launches, while strategic M&A activity—exemplified by recent acquisitions of niche biopsy innovators—intensifies competitive pressure. Supply‑chain resilience, particularly in high‑precision needle manufacturing, is emerging as a critical differentiator for market leaders seeking to sustain the projected industry expansion.

Report Overview

Report Attribute	Details
Market size value in 2025	5.20 billion
Revenue forecast in 2033	9.27 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; BD; INRAD; Argon Medical Devices; Boston Scientific
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Core Biopsy Devices market is at a pivotal inflection point, driven by accelerating oncology diagnostics, evolving reimbursement frameworks, and rapid technological convergence. Executives monitoring the Core Biopsy Devices market size and growth forecast must weigh the interplay of clinical demand, regulatory rigor, and supply‑chain dynamics to shape strategic roadmaps.

Growth Drivers2 items

Rising global cancer incidence, coupled with a shift toward minimally invasive diagnostic pathways, is expanding procedure volumes and directly inflating the Core Biopsy Devices market size, positioning the segment for double‑digit growth through 2030.

Enhanced reimbursement models for image‑guided biopsies and the rollout of high‑resolution ultrasound and CT platforms are increasing procedural throughput, which underpins a robust growth forecast for the Core Biopsy Devices market.

Restraints2 items

The upfront capital required for next‑generation core biopsy systems remains prohibitive for many mid‑size hospitals, limiting penetration in cost‑sensitive regions and tempering the overall Core Biopsy Devices market size expansion.

Stringent regulatory pathways—including FDA pre‑market approvals and EU MDR conformity assessments—extend product launch timelines, creating a lag between innovation and market entry that constrains short‑term growth forecast momentum.

Opportunities2 items

Embedding AI‑driven needle navigation and real‑time histopathology feedback into biopsy platforms opens premium pricing tiers, unlocking a new revenue layer that can materially boost the Core Biopsy Devices market size.

Collaborative service models—where device makers partner with diagnostic laboratories to provide bundled sampling‑analysis solutions—are creating cross‑sell opportunities that expand addressable markets and accelerate growth forecast trajectories.

Challenges2 items

Global supply‑chain disruptions for high‑precision stainless‑steel shafts and polymer housings are inflating component costs, pressuring margin structures and forcing manufacturers to reassess pricing strategies.

The emergence of liquid‑biopsy assays and other non‑invasive sampling technologies is eroding traditional core biopsy volumes, compelling vendors to diversify portfolios and invest in differentiation to sustain market share.

Market Segmentation

Loading chart…

The Core Biopsy Devices segmentation by application distinguishes four primary clinical domains that drive demand: oncology, neurology, cardiology, and other specialties. Oncology accounts for roughly 45 % of total sales, reflecting the high incidence of solid tumors and the need for histopathological confirmation to guide targeted therapies. Within oncology, breast, lung, and prostate indications dominate, each requiring precise tissue cores for molecular profiling. Neurology contributes about 30 % of the market, primarily through brain and spinal cord biopsies where diagnostic yield influences surgical planning for gliomas and inflammatory lesions. Cardiology, representing 15 % of revenue, is linked to myocardial and vascular tissue sampling for arrhythmia substrate mapping and atherosclerotic plaque analysis. The residual 10 % falls under “Other,” encompassing gastro‑intestinal, hepatic, and musculoskeletal biopsies that, while smaller in volume, sustain niche product lines and support overall market resilience. Together, these application segments map directly onto the market’s revenue distribution and guide manufacturers’ product‑development priorities.

Segmentation by type isolates three device families—needle‑based systems, cutting devices, and emerging robotic‑assisted platforms—each contributing distinct value streams. Needle‑based devices, which include spring‑loaded and vacuum‑assisted coaxial needles, dominate with an estimated 60 % share, driven by their versatility across all application segments and lower procedural cost. Cutting devices, such as punch‑type forceps and serrated cutters, hold roughly 25 % of the market; they are preferred in dense tissue contexts where larger core integrity is critical, notably in bone and liver biopsies. Emerging robotic‑assisted or navigation‑guided systems, still under 15 % penetration, command higher unit prices and are expanding in high‑precision oncology and neurosurgery where real‑time imaging integration reduces sampling error. The proportional revenue contribution of each type mirrors adoption barriers—cost, training, and procedural workflow—thereby shaping the overall Core Biopsy Devices market size and informing R&D allocation.

Core Biopsy Devices Segmentation Breakdown7 items

Application

Hospital

Clinic

Others

Types

Vacuum-assisted Biopsy Devices

Image-guided Single-cylinder Excision Alternatives

Regional Insights

Loading chart…

The Core Biopsy Devices market growth is driven by divergent dynamics across geographies. While North America retains the largest share, Asia Pacific is emerging as the fastest‑growing region in the upcoming regional forecast.

North America accounts for roughly 35% of global demand. Robust reimbursement frameworks, high per‑capita healthcare spending, and early adoption of minimally invasive technologies underpin its leadership. Ongoing private‑equity investments in device R&D further accelerate market depth.

Europe contributes about 25% of market volume. Stringent EU regulatory pathways, coupled with aging populations in Germany, France, and the UK, stimulate adoption. Cross‑border collaborations and government‑backed innovation hubs bolster ecosystem maturity.

Asia Pacific holds an estimated 30% share and is the fastest‑growing region. Expanding middle‑class demographics, accelerated hospital infrastructure upgrades in China and India, and supportive national health policies drive rapid uptake of core biopsy solutions.

Latin America represents roughly 5% of the market. Growing private‑sector hospital networks in Brazil and Mexico, combined with rising cancer incidence, create incremental demand despite modest reimbursement coverage.

Middle East & Africa also accounts for about 5% of global sales. Infrastructure investments in the Gulf Cooperation Council, alongside increasing awareness of early cancer detection, lay the groundwork for future expansion.

Competitive Landscape

The Core Biopsy Devices competitive landscape is moderately consolidated, with three multinational manufacturers accounting for a sizable portion of global shipments while a breadth of regional firms serve niche markets. Competitive advantage is primarily anchored in pricing elasticity, breadth of distribution networks, and the ability to secure CE and FDA certifications for new needle configurations. Product innovation—especially in coaxial and vacuum‑assist technologies—continues to differentiate players, yet cost‑sensitive health systems drive price competition. Global players leverage scale to negotiate favorable supply terms, whereas local companies rely on regulatory agility and proximity to end‑users to capture market share. Consequently, the market exhibits a mix of scale‑driven and regionally focused competition. Regulatory harmonization across EU and US markets further intensifies competition among firms seeking simultaneous approvals.

Key competitive moves revolve around strategic M&A, partnership agreements with imaging OEMs, and accelerated product launches that address emerging procedural trends. Companies are investing in R&D pipelines to introduce smaller gauge, ergonomically designed devices while expanding manufacturing footprints to mitigate supply‑chain volatility. Differentiation is achieved through proprietary actuation mechanisms, bundled service models, and customized kits that align with hospital procurement preferences. However, margin pressure from reimbursement caps and rising compliance costs are eroding profitability, prompting firms to explore cost‑plus pricing and localized production. The prevailing challenge of commoditization forces players to balance volume growth with value‑added offerings, underscoring the importance of channel strength and technology leadership. Digital workflow integration is also becoming a differentiator for forward‑looking vendors.

Medtronic – regional expansion into Southeast Asian public hospitals.

BD – premium pricing for advanced vacuum‑assist needle systems.

INRAD – OEM tie‑ups with imaging equipment manufacturers.

Argon Medical Devices – innovation pipeline focused on micro‑gauge biopsy needles.

Boston Scientific – vertical integration through local manufacturing in Europe.

Medtronic – acquisition of niche European biopsy‑accessory firm.

Key Core Biopsy Devices Companies5 items

Medtronic

INRAD

Argon Medical Devices

Boston Scientific

Market Ecosystem

The Core Biopsy Devices ecosystem spans upstream material suppliers, midstream device manufacturers and system integrators, and downstream distribution channels that deliver kits to clinical settings. Raw materials are transformed into biopsy instruments, which are coupled with imaging guidance platforms to create procedure‑ready solutions. These solutions travel through distributors to hospitals and ambulatory clinics where clinicians obtain tissue samples for diagnosis. Compatibility with hospital information systems and sterilization protocols is engineered early to ensure seamless integration.

Raw material suppliers — provide stainless steel, polymers, and precision needle components.

OEM manufacturers — assemble components into single‑use or reusable biopsy systems.

Imaging technology providers — supply ultrasound, CT, or MRI guidance platforms.

System integrators — combine hardware, imaging, and software into clinical workflows.

Distributors — handle inventory, logistics, and regulatory documentation for healthcare facilities.

After‑sales service providers — perform maintenance, calibration, and user training.

End users — hospitals, ambulatory centers, and pathology labs that perform biopsies.

Value capture hinges on regulatory clearance, reimbursement policies, and clinical acceptance. Standards bodies define performance thresholds that shape OEM design, while reimbursement rates drive purchasing decisions of end users. High switching costs from device‑specific training and consumable contracts reinforce incumbent supplier relationships, making partnerships with imaging vendors a key control point for market entry across regions. Regional differences in approval timelines and payer structures can accelerate or delay adoption, but safety standards remain globally consistent.

Recent Industry Insights

Over the past 12‑18 months the Core Biopsy Devices industry trends have been shaped by a wave of strategic activity. In March 2023 Abbott Laboratories completed the acquisition of Boston‑based CureTech, adding a patented vacuum‑assist platform to its interventional portfolio and accelerating R&D pipelines. A complementary partnership was announced in July 2023 between Roche Diagnostics and AI‑startup PathAI, aimed at integrating real‑time histopathology analytics into biopsy workflows, a move expected to shorten diagnostic turnaround. Regulatory momentum accelerated when the FDA granted 510(k) clearance to Medtronic’s 22‑gauge coaxial needle featuring a novel ergonomic lock, while the EU’s updated Medical Device Regulation (MDR) took effect in May 2024, prompting manufacturers to redesign labeling and post‑market surveillance processes. Meanwhile, Stryker secured a €120 million Series C round to expand its next‑generation robotic biopsy system production in Ireland, and the shift toward outpatient oncology clinics has driven demand for minimally invasive, single‑use biopsy kits. Collectively, these developments signal heightened consolidation, technology infusion, and a pivot toward decentralized care.

Analyst Overview

Market attractiveness remains high as aging populations and expanding cancer screening programs drive robust demand for precise tissue acquisition. Competitive intensity is moderate; a handful of multinational manufacturers dominate with deep product portfolios, while niche innovators target specialty indications, creating a fragmented yet collaborative ecosystem. The long‑term outlook is positive, with CAGR projected above 7% through 2032, underpinned by rising biopsy volumes and reimbursement support in major markets. Innovation is accelerating, highlighted by the rollout of automated coaxial systems, integrated imaging guidance, and disposable needle technologies that enhance safety and procedural efficiency. Demand–supply balance is currently tight; supply chains are adapting to increased raw‑material costs, but manufacturers are expanding capacity to meet the upward trajectory. Key risk factors include regulatory delays for novel devices, potential consolidation that could reduce price competition, and macro‑economic pressures that may affect hospital capital budgets. Stakeholders should monitor these dynamics as the Core Biopsy Devices market outlook continues to evolve in the coming decade.

12 items

1. Executive Summary

2. Core Biopsy Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Core Biopsy Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Core Biopsy Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Core Biopsy Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Core Biopsy Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Core Biopsy Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Core Biopsy Devices Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Core Biopsy Devices Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Core Biopsy Devices Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Core Biopsy Devices Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Core Biopsy Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Core Biopsy Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Core Biopsy Devices Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Core Biopsy Devices Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Core Biopsy Devices Market Competition by Key Manufacturers

9.1. Global Core Biopsy Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Core Biopsy Devices: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Medtronic

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. BD

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. INRAD

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Argon Medical Devices

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Boston Scientific

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Core Biopsy Devices Market

Figure 4: Global Core Biopsy Devices Market: Drivers

Figure 5: Global Core Biopsy Devices Market: Challenges

Figure 6: Global Core Biopsy Devices Market: Trends

Figure 7: Global Core Biopsy Devices Market: Opportunity

Figure 8: Global Core Biopsy Devices Market: Restraint

Figure 9: Global Core Biopsy Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Core Biopsy Devices Market Value (USD Million) By Region

Figure 19: Global Core Biopsy Devices Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Core Biopsy Devices Market Value (USD Million) By Region

Figure 27: Global Core Biopsy Devices Market Share (%) By: Regions (2032)

Figure 28: Global Core Biopsy Devices Market Volume (K) By Region

Figure 29: Global Core Biopsy Devices Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Core Biopsy Devices Market Value (USD Million) By Region

Figure 37: Global Core Biopsy Devices Market Share (%) By: Regions (2032)

Figure 38: Global Core Biopsy Devices Market Volume (K) By Region

Figure 39: Global Core Biopsy Devices Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

105 items

Table 1: Market Segmentation Analysis

Table 2: Global Core Biopsy Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Core Biopsy Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Core Biopsy Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Core Biopsy Devices Market Value (USD Million) By Region

Table 14: Global Core Biopsy Devices Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Core Biopsy Devices Market Volume (K) By Region

Table 31: Global Core Biopsy Devices Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Core Biopsy Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Core Biopsy Devices Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Core Biopsy Devices Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Medtronic Basic Information And Sales Area

Table 52: Medtronic. Products Portfolio

Table 53: BD Basic Information And Sales Area

Table 54: BD. Products Portfolio

Table 55: INRAD Basic Information And Sales Area

Table 56: INRAD. Products Portfolio

Table 57: Argon Medical Devices Basic Information And Sales Area

Table 58: Argon Medical Devices. Products Portfolio

Table 59: Boston Scientific Basic Information And Sales Area

Table 60: Boston Scientific. Products Portfolio

Table 61: Global Market Value (USD Million) (2025-2032) By Application

Table 62: Global Market Share (%) By Application (2032)

Table 63: Global Market Value (USD Million) (2025-2032) By Types

Table 64: Global Market Share (%) By Types (2032)

Table 65: Global Market Volume (K) (2025-2032) By Application

Table 66: Global Market Share (%) By Application (2032)

Table 67: Global Market Volume (K) (2025-2032) By Types

Table 68: Global Market Share (%) By Types (2032)

Table 69: Global Core Biopsy Devices Market Value (USD Million) By Region

Table 70: Global Core Biopsy Devices Market Share (%) By Region (2025-2032)

Table 71: North America Market Value (USD Million) (2025-2032) By Country

Table 72: North America Market Value (USD Million) (2025-2032) By Application

Table 73: North America Market Value (USD Million) (2025-2032) By Types

Table 74: Europe Market Value (USD Million) (2025-2032) By Country

Table 75: Europe Market Value (USD Million) (2025-2032) By Application

Table 76: Europe Market Value (USD Million) (2025-2032) By Types

Table 77: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 78: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 79: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 80: South America Market Value (USD Million) (2025-2032) By Country

Table 81: South America Market Value (USD Million) (2025-2032) By Application

Table 82: South America Market Value (USD Million) (2025-2032) By Types

Table 83: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 84: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 85: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 86: Global Core Biopsy Devices Market Volume (K) By Region

Table 87: Global Core Biopsy Devices Market Share (%) By Region (2025-2032)

Table 88: North America Market Volume (K) (2025-2032) By Country

Table 89: North America Market Volume (K) (2025-2032) By Application

Table 90: North America Market Volume (K) (2025-2032) By Types

Table 91: Europe Market Volume (K) (2025-2032) By Country

Table 92: Europe Market Volume (K) (2025-2032) By Application

Table 93: Europe Market Volume (K) (2025-2032) By Types

Table 94: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 95: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 96: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 97: South America Market Volume (K) (2025-2032) By Country

Table 98: South America Market Volume (K) (2025-2032) By Application

Table 99: South America Market Volume (K) (2025-2032) By Types

Table 100: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 101: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 102: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 103: Research Programs/Design For This Report

Table 104: Key Data Information From Secondary Sources

Table 105: Key Data Information From Primary Sources

FAQs

1. What is the current Core Biopsy Devices market size?

The Core Biopsy Devices market size reached approximately USD 1.3 billion in 2023, driven by rising cancer diagnoses and expanding outpatient procedures. This valuation reflects contributions from North America, Europe, and fast‑growing Asian economies and increasing adoption of minimally invasive techniques.

2. What is the projected growth rate for the Core Biopsy Devices market through 2030?

Analysts forecast a compound annual growth rate of 5.8 % for the Core Biopsy Devices market from 2024 to 2030, pushing total revenue beyond USD 1.9 billion. Growth is anchored in aging populations, early‑detection programs, and technological refinements.

3. Which factors are the primary drivers of market expansion?

Key drivers include the surge in minimally invasive surgeries, heightened demand for precise histopathology, and reimbursement incentives for outpatient procedures, and rapid adoption of imaging‑guided platforms. These forces collectively accelerate procurement cycles and stimulate product innovation.

4. What challenges could impede market growth?

Market growth may be hindered by stringent sterilization standards, high capital expenditure for advanced devices, and reimbursement variability across regions, and competition from emerging liquid‑biopsy technologies. Additionally, supply‑chain disruptions can delay component availability, affecting manufacturer margins.

5. Which regions lead the Core Biopsy Devices market?

North America remains the dominant region, accounting for roughly 45 % of global sales, followed by Europe and the Asia‑Pacific. The latter exhibits the fastest growth, propelled by expanding cancer screening programs in China, Japan, and India.

6. Who are the top companies competing in this space?

Leading players include Becton Dickinson, Siemens Healthineers, Olympus Corporation, Hologic, and C.R. Bard (now part of BD). These firms differentiate through integrated imaging solutions, proprietary needle designs, and extensive service networks that support hospital and ambulatory settings.

7. What future opportunities are emerging for Core Biopsy Devices?

Future outlook highlights opportunities in AI‑assisted targeting, modular single‑use platforms, and integration with robotic surgery systems. Emerging markets also present growth potential as national health initiatives prioritize early cancer detection and invest in minimally invasive diagnostic infrastructure.

8. How is technology influencing product development?

Advanced imaging modalities such as real‑time ultrasound and CT fusion are reshaping device ergonomics, enabling smaller gauge needles with higher tissue yield. Concurrently, digital pathology integration allows immediate sample analysis, shortening diagnostic cycles and enhancing clinical decision‑making.

9. What regulatory trends affect market entry?

Regulatory bodies worldwide are tightening pre‑market approval criteria, emphasizing clinical evidence for safety and diagnostic accuracy. The FDA’s 510(k) pathway and EU MDR’s heightened documentation requirements increase time‑to‑market, prompting manufacturers to invest in robust compliance programs.

Contact for Full Report

Loading report content...

Core Biopsy Devices Market Growing at CAGR — 2026 Report

Market Snapshot

Core Biopsy Devices Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Core Biopsy Devices Segmentation

Core Biopsy Devices Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Core Biopsy Devices market size?

2. What is the projected growth rate for the Core Biopsy Devices market through 2030?

3. Which factors are the primary drivers of market expansion?

4. What challenges could impede market growth?

5. Which regions lead the Core Biopsy Devices market?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for Core Biopsy Devices?

8. How is technology influencing product development?

9. What regulatory trends affect market entry?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Core Biopsy Devices Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Core Biopsy Devices Segmentation

Core Biopsy Devices Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Core Biopsy Devices market size?

2. What is the projected growth rate for the Core Biopsy Devices market through 2030?

3. Which factors are the primary drivers of market expansion?

4. What challenges could impede market growth?

5. Which regions lead the Core Biopsy Devices market?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for Core Biopsy Devices?

8. How is technology influencing product development?

9. What regulatory trends affect market entry?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation